Dupixent Lawsuit in Georgia - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Georgia is the single most important state in the Dupixent CTCL litigation because plaintiffs have proposed the Northern District of Georgia (Atlanta) as the MDL transferee court. If the JPML grants MDL No. 3180 and selects Atlanta, all federal Dupixent cases nationwide will be consolidated in Georgia for pretrial proceedings. Beyond its procedural significance, Georgia is home to an estimated 82,000 Dupixent patients — a large exposure population concentrated in the Atlanta metropolitan area. Winship Cancer Institute at Emory University, Georgia's only NCI-designated cancer center, provides specialized cutaneous lymphoma diagnostic and treatment capabilities. Georgia's 2-year product liability SOL is standard, and the state's discovery rule is well-established for latent pharmaceutical injuries. The Northern District of Georgia has managed complex litigation efficiently, and Atlanta's diverse jury pools have shown willingness to hold pharmaceutical companies accountable in past cases.

Written By

People's Justice Legal Research Team

Statute of Limitations

Georgia: 2 years for product liability (Ga. Code Ann. § 9-3-33). Discovery rule applies — the statute begins when the plaintiff discovers or should have discovered the injury and its connection to the product.

2 years from discovery of injury

Filing Venue

Where to File in Georgia

Georgia has three federal districts: the Northern District (Atlanta), Middle District (Macon), and Southern District (Savannah). The Northern District of Georgia is the proposed plaintiff venue for Dupixent MDL consolidation — making it the most important district in the litigation. Atlanta's federal courthouse has experienced judges, efficient case management, and a plaintiff bar with significant pharmaceutical litigation experience. Georgia does not cap compensatory damages in product liability cases.

Georgia Data

Exposure in Georgia

Source: IQVIA prescription data estimates

Source: Winship Cancer Institute / NCI

Source: JPML MDL Petition Records

FAQ

Frequently Asked Questions

See details below.

Back to Dupixent Lawsuit Lawsuit Overview